Skip to main content

Table 3 Demographic and psychometric data

From: Neurochemical sex differences in adult ADHD patients: an MRS study

  mADHD (n = 48) fADHD (n = 48) p value mADHD (n = 42) fADHD (n = 42) p value
pACC Cerebellum
Age 33.67 ± 9.911 33.75 ± 9.710 0.967 33.24 ± 10.024 33.17 ± 9.740 0.974
IQ 112.31 ± 15.764 112.23 ± 15.896 0.979 111.79 ± 16.728 112.31 ± 16.418 0.885
WURS-k 39.67 ± 7.467 40.48 ± 9.876 0.650 39.88 ± 7.494 40.60 ± 10.296 0.717
CAARS-inattention 72.98 ± 14.734 74.00 ± 11.924 0.710 73.19 ± 14.737 72.45 ± 12.292 0.804
CAARS-hyperactivity-impulsivity 56.96 ± 13.483 56.13 ± 13.695 0.765 57.93 ± 13.659 54.71 ± 13.834 0.287
CAARS-total symptoms 68.10 ± 13.726 67.75 ± 11.964 0.893 68.86 ± 14.465 65.60 ± 11.698 0.259
CAARS-ADHD Index 64.15 ± 12.821 69.00 ± 11.082 0.050 64.95 ± 13.046 68.00 ± 10.992 0.250
BDI 9.25 ± 6.6270 13.96 ± 8.901 0.004** 9.62 ± 6.748 13.43 ± 897.461 0.031*
Nicotine 7.31 ± 11.532 4.71 ± 10.372 0.248 8.19 ± 12.047 3.69 ± 7.303 0.042*
  1. Abbreviations: IQ intelligence quotient (measured by the MWTB Multiple-Choice Vocabulary Intelligence Test), mADHD adult male ADHD patients, fADHD adult female ADHD patients, WURS-k Wender Utah Rating Scale, CAARS-S:L Conners Adult ADHD Rating Scales-Self Report: Long Version, BDI Beck Depression Inventory, nicotine nicotine consumption in cigarettes per day. For reference see text
  2. *p < 0.05, **p < 0.01